SFSIG
IPXL

San Francisco Sentry Investment Group’s Impax Laboratories, Inc. IPXL Stock Holding History

San Francisco Sentry Investment Group’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-163
Closed -$3K – 934
2018
Q1 		$3K Buy
163
+16
+11% +$314 ﹤0.01% 831
2017
Q4 		$2K Buy
+147
New +$2.69K ﹤0.01% 867

San Francisco Sentry Investment Group's IPXL Position: Q2 2018 in Review

San Francisco Sentry Investment Group sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 163 shares — an estimated $3K sold.

San Francisco Sentry Investment Group first reported a position in IPXL in Q4 2017 and held it in 2 quarters. The position peaked at $3K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • San Francisco Sentry Investment Group reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 163 Impax Laboratories, Inc. shares in Q2 2018, an estimated $3K.
  • San Francisco Sentry Investment Group first reported a position in Impax Laboratories, Inc. in Q4 2017 and held it in 2 quarters.
  • San Francisco Sentry Investment Group's Impax Laboratories, Inc. position peaked at $3K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2018, filed 6 Aug 2018.